You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Nitrofurantoin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for nitrofurantoin and what is the scope of patent protection?

Nitrofurantoin is the generic ingredient in eight branded drugs marketed by Watson Labs, Casper Pharma Llc, Actavis Mid Atlantic, Amneal Pharms, Aurobindo Pharma, Nostrum Labs Inc, Novel Labs Inc, Novitium Pharma, Procter And Gamble, Chartwell Molecular, Elkins Sinn, Ivax Sub Teva Pharms, Sandoz, Whiteworth Town Plsn, Almatica, Actavis Labs Fl Inc, Alembic, Athem, Aurobindo Pharma Usa, Impax Labs Inc, Mankind Pharma, Sun Pharm Industries, Zydus Pharms, Alvogen, Chartwell Rx, Inventia, Micro Labs, Ranbaxy Labs Ltd, Sunny, and Watson Labs Inc, and is included in forty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for nitrofurantoin. Eleven suppliers are listed for this compound.

Summary for nitrofurantoin
Drug Prices for nitrofurantoin

See drug prices for nitrofurantoin

Drug Sales Revenue Trends for nitrofurantoin

See drug sales revenues for nitrofurantoin

Recent Clinical Trials for nitrofurantoin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MinnesotaEarly Phase 1
Walter Reed National Military Medical CenterPhase 2
Goodlife Pharma B.V.Phase 4

See all nitrofurantoin clinical trials

Pharmacology for nitrofurantoin
Medical Subject Heading (MeSH) Categories for nitrofurantoin

US Patents and Regulatory Information for nitrofurantoin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athem NITROFURANTOIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 074336-002 Jan 25, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sunny NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 208516-001 May 24, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs NITROFURANTOIN MACROCRYSTALLINE nitrofurantoin, macrocrystalline CAPSULE;ORAL 070248-001 Jun 24, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novel Labs Inc NITROFURANTOIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 203233-001 Jul 9, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs NITROFURANTOIN nitrofurantoin TABLET;ORAL 085796-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 209225-001 Mar 30, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.